FAFGX | FNICX | FAFGX / FNICX | |
Total Expense Ratio | 0.40 | 1.65 | 24% |
Annual Report Gross Expense Ratio | 0.40 | 1.65 | 24% |
Fund Existence | 5 years | 22 years | - |
Gain YTD | 13.444 | 11.517 | 117% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 250 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 328B | 23.4B | 1,402% |
Annual Yield % from dividends | 0.53 | 0.03 | 1,886% |
Returns for 1 year | 18.07 | 16.79 | 108% |
Returns for 3 years | 60.25 | 43.73 | 138% |
Returns for 5 years | N/A | 17.65 | - |
Returns for 10 years | N/A | 30.35 | - |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
BCHP | 37.87 | 0.18 | +0.48% |
Principal Focused Blue Chip ETF | |||
CGCP | 22.46 | 0.04 | +0.18% |
Capital Group Core Plus Income ETF | |||
TBUX | 49.90 | 0.03 | +0.05% |
T. Rowe Price Ultra Short-Term Bond ETF | |||
MSTQ | 36.89 | -0.02 | -0.05% |
LHA Market State™ Tactical Q ETF | |||
LFSC | 24.72 | -0.03 | -0.10% |
F/m Emerald Life Sciences Innovation ETF |